Categories: EnergyTechHardwareMarketMedTechProductTechnology
Syneron (NASDAQ: ELOS) develops, manufactures and markets medical aesthetic devices based on the ELOS combined energy technology (Electro-Optical Synergy) using Bi-Polar Radio Frequency and Light. The company’s products have superior safety features comparing to other devices on the market, with equal or even better efficacy
Investors 1
Mentions in press and media 3
| Date | Title | Description |
| 25.03.2025 | Tariff Flexibility: A Double-Edged Sword for Markets | In the world of finance, uncertainty is like a storm cloud. It looms, casting shadows over markets and making investors uneasy. Recently, U.S. President Donald Trump hinted at “flexibility” regarding tariffs. This word, while seemingly beni... |
| 24.03.2025 | CNBC Daily Open: Tariff flexibility sounds good, but also signals uncertainty | “Flexibility” connotes openness to change. U.S. President Donald Trump expressed Friday the possibility of being flexible with tariffs, which may have helped stocks tick up, pushing the three key U.S. benchmarks into the green for the week.... |
| 05.01.2010 | UPDATE: Syneron closes $65 million Candela merger | Syneron Medical Ltd. (NSDQ:ELOS) closed a deal to snap up one of its main rivals, Candela Corp. (NSDQ:CLZR), for $65 million, leaving its shareholders owning 80 percent of the company and former Candela owners with a 20 percent stake.
The c... |
Reviews 0
